Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by Dana-Farber Cancer Institute
Sponsor:
Collaborator:
National Comprehensive Cancer Network
Information provided by (Responsible Party):
Danielle Margalit, MD, MPH, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01783587
First received: January 30, 2013
Last updated: July 14, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2018
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)